Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Long-Term Deferred Tax (2016 - 2025)

Fresenius Medical Care AG (FMS) has 16 years of Long-Term Deferred Tax data on record, last reported at $275.4 million in Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax rose 12.27% year-over-year to $275.4 million; the TTM value through Dec 2025 reached $275.4 million, up 12.27%, while the annual FY2025 figure was $267.3 million, 7.59% up from the prior year.
  • Long-Term Deferred Tax reached $275.4 million in Q4 2025 per FMS's latest filing, up from $245.3 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $360.8 million in Q4 2021 and bottomed at $245.3 million in Q4 2024.
  • Average Long-Term Deferred Tax over 4 years is $300.1 million, with a median of $297.2 million recorded in 2022.
  • Peak YoY movement for Long-Term Deferred Tax: dropped 13.83% in 2021, then rose 12.27% in 2025.
  • A 4-year view of Long-Term Deferred Tax shows it stood at $360.8 million in 2021, then fell by 11.57% to $319.0 million in 2022, then decreased by 23.12% to $245.3 million in 2024, then rose by 12.27% to $275.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Deferred Tax were $275.4 million in Q4 2025, $245.3 million in Q4 2024, and $319.0 million in Q4 2022.